Not Tagged
Not Tagged
[]
delighted to present a 10-year experience of mcrc patients participating in ph i trials. the sarah cannon research institute uk #gi23 ph 1 offers a reasonable therapeutic approach and early access to drugs with potential to become new standard of care. 
GI Medical Oncologist. Cancer Researcher.